These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33421136)

  • 1. Surgical Management of Cervical Non-seminomatous Germ Cell Tumor Metastases.
    Nwosu OI; Jones AJ; Alwani M; Einhorn LH; Moore MG; Mantravadi AV
    Laryngoscope; 2021 Jul; 131(7):1528-1534. PubMed ID: 33421136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer.
    Masterson TA; Shayegan B; Carver BS; Bajorin DF; Feldman DR; Motzer RJ; Bosl GJ; Sheinfeld J
    Urology; 2012 Jan; 79(1):156-9. PubMed ID: 22202548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.
    Dowling CM; Assel M; Musser JE; Meeks JJ; Sjoberg DD; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
    Urology; 2018 Apr; 114():133-138. PubMed ID: 29410311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiated rhabdomyomatous tumors after chemotherapy for metastatic testicular germ-cell tumors: a clinicopathological study of seven cases mandating separation from rhabdomyosarcoma.
    Clevenger JA; Foster RS; Ulbright TM
    Mod Pathol; 2009 Oct; 22(10):1361-6. PubMed ID: 19633644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolent nonseminomatous germ cell tumor of testis. Prolonged survival of patient with persistent metastatic disease.
    Baker TM; Chan AH; Stutz FH
    Urology; 1986 Apr; 27(4):349-52. PubMed ID: 3008399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between primary and metastatic testicular germ cell tumors: a clinicopathologic analysis of 100 cases.
    Tarrant WP; Czerniak BA; Guo CC
    Hum Pathol; 2013 Oct; 44(10):2220-6. PubMed ID: 23856516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in the management of stage 1 non-seminomatous germ cell tumors.
    Coleman S; Stephenson A
    Curr Urol Rep; 2013 Oct; 14(5):506-10. PubMed ID: 23901036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroperitoneal lymph node dissection as adjuvant therapy in the treatment of non-seminomatous testicular cancer.
    Thijssens K; Vaneerdeweg W; Schrijvers D; Eyskens E; Van Oosterom A
    Acta Chir Belg; 2003; 103(6):599-602. PubMed ID: 14743567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease?
    Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M
    Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
    Hiester A; Nini A; Arsov C; Buddensieck C; Albers P
    J Urol; 2020 Dec; 204(6):1242-1248. PubMed ID: 32717162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
    Aparicio J; Sánchez-Muñoz A; Ochenduszko S; Gumà J; Fernández-Aramburo A; García Del Muro X; Quiroga V; Sastre J; Alonso-Gordoa T; Sagastibelza N; Maroto P; Gómez de Liaño A; Vázquez S; Diz P; Durán I; Domenech M; Pinto A; Hernández A; González-Billalabeitia E; Terrasa J
    J Urol; 2019 Oct; 202(4):742-747. PubMed ID: 31163007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes in patients with stage I non-seminomatous germ cell cancer.
    Lv ZJ; Wu S; Dong P; Yao K; He YY; Gui YT; Zhou FJ; Liu ZW; Cai ZM
    Asian J Androl; 2013 Jul; 15(4):558-63. PubMed ID: 23685909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissection.
    Baessler B; Nestler T; Pinto Dos Santos D; Paffenholz P; Zeuch V; Pfister D; Maintz D; Heidenreich A
    Eur Radiol; 2020 Apr; 30(4):2334-2345. PubMed ID: 31828413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness of Risk-adapted Surveillance vs Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: A Retrospective Follow-up Study of 81 Patients.
    Fan G; Zhang L; Yi L; Jiang ZQ; Ke Y; Wang XS; Xiong YY; Han WQ; Zhou X; Liu C; Yu X
    Asian Pac J Cancer Prev; 2015; 16(8):3267-72. PubMed ID: 25921130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer.
    Mano R; Di Natale R; Sheinfeld J
    Urol Oncol; 2019 Mar; 37(3):209-218. PubMed ID: 30446455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor.
    Taza F; Chovanec M; Snavely A; Hanna NH; Cary C; Masterson TA; Foster RS; Einhorn LH; Albany C; Adra N
    J Clin Oncol; 2020 Apr; 38(12):1338-1345. PubMed ID: 32134699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
    Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
    Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
    Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
    Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
    Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
    J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.